Patient preference is leaning towards Eli Lilly’s weight loss drugs, says Guggenheim’s Fernandez
Seamus Fernandez, Guggenheim managing director, joins 'Power Lunch' to discuss the battle between Novo Nordisk and Eli Lilly. For access ...
Seamus Fernandez, Guggenheim managing director, joins 'Power Lunch' to discuss the battle between Novo Nordisk and Eli Lilly. For access ...
Treasury Secretary Scott Bessent testifies before the House Financial Services Committee on Wednesday. For access to live and exclusive video ...
Stephen Parker, JPMorgan Private Bank co-head of global investment strategy, joins 'Squawk Box' to discuss the latest market trends, 2026 ...
The House of Representatives on Tuesday narrowly passed a bill to end the three-day partial shutdown of much of the ...
Disney’s new CEO is longtime company veteran Josh D’Amaro. After several leadership roles within the company, he took over the ...
For the past nearly 20 years, Disney has been led by Bob Iger, who spearheaded some of the company's most ...
Listen to Jim Cramer’s personal guide through the confusing jungle of Wall Street investing, navigating through opportunities and pitfalls with ...
Katie Stockton, Fairlead Strategies founder and managing partner, joins 'Squawk Box' to discuss the latest market trends, state of the ...
Blackstone President and COO Jon Gray joins 'Squawk Box' to discuss the company's quarterly earnings results, investing in AI, dealmaking ...
Joyce Chang, JPMorgan Chair of Global Research, Tom Lee, Head of Research at Fundstrat Global Advisors, and Michelle Caruso-Cabrera, CEO ...
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.